Rapid Micro Biosystems (RPID) Stock Forecast, Price Target & Predictions
RPID Stock Forecast
Rapid Micro Biosystems stock forecast is as follows: an average price target of $8.00 (represents a 858.08% upside from RPID’s last price of $0.83) and a rating consensus of 'Hold', based on 1 wall street analysts offering a 1-year stock forecast.
RPID Price Target
RPID Analyst Ratings
Rapid Micro Biosystems Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
May 11, 2022 | - | Morgan Stanley | $8.00 | $4.11 | 94.65% | 858.08% |
Rapid Micro Biosystems Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $0.83 | $0.83 | $0.83 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 11, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Rapid Micro Biosystems Financial Forecast
Rapid Micro Biosystems Revenue Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $6.34M | $6.14M | $5.00M | $5.04M | $4.37M | $4.74M | $3.86M | $4.16M | $5.21M | $6.90M | $6.13M |
Avg Forecast | $7.82M | $7.61M | $7.40M | $7.19M | $8.40M | $6.55M | $6.00M | $5.50M | $6.15M | $5.55M | $4.15M | $4.13M | $4.50M | $3.97M | $4.35M | $5.16M | $5.87M | $6.57M | $5.93M |
High Forecast | $8.12M | $7.90M | $7.68M | $7.47M | $8.72M | $6.58M | $6.23M | $5.71M | $6.23M | $5.76M | $4.31M | $4.29M | $4.67M | $4.12M | $4.44M | $5.27M | $5.99M | $6.71M | $6.06M |
Low Forecast | $7.52M | $7.31M | $7.11M | $6.92M | $8.08M | $6.52M | $5.77M | $5.29M | $6.07M | $5.34M | $3.99M | $3.98M | $4.33M | $3.82M | $4.26M | $5.05M | $5.74M | $6.42M | $5.80M |
# Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 |
Surprise % | - | - | - | - | - | - | - | - | 1.03% | 1.11% | 1.21% | 1.22% | 0.97% | 1.19% | 0.89% | 0.81% | 0.89% | 1.05% | 1.03% |
Rapid Micro Biosystems EBITDA Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 |
EBITDA | - | - | - | - | - | - | - | - | $-12.48M | $-14.45M | $-15.05M | $-14.87M | $-17.26M | $-16.15M | $-13.69M | $-14.34M | $-14.14M | $-25.36M | $-10.54M |
Avg Forecast | $-7.82M | $-7.61M | $-7.40M | $-7.19M | $-8.40M | $-6.55M | $-6.00M | $-5.50M | $-6.15M | $-5.55M | $-4.15M | $-4.13M | $-4.50M | $-27.16M | $-4.35M | $-13.47M | $-5.87M | $-6.57M | $-443.86M |
High Forecast | $-7.52M | $-7.31M | $-7.11M | $-6.92M | $-8.08M | $-6.52M | $-5.77M | $-5.29M | $-6.07M | $-5.34M | $-3.99M | $-3.98M | $-4.33M | $-21.73M | $-4.26M | $-10.77M | $-5.74M | $-6.42M | $-355.09M |
Low Forecast | $-8.12M | $-7.90M | $-7.68M | $-7.47M | $-8.72M | $-6.58M | $-6.23M | $-5.71M | $-6.23M | $-5.76M | $-4.31M | $-4.29M | $-4.67M | $-32.59M | $-4.44M | $-16.16M | $-5.99M | $-6.71M | $-532.64M |
Surprise % | - | - | - | - | - | - | - | - | 2.03% | 2.60% | 3.63% | 3.60% | 3.84% | 0.59% | 3.15% | 1.06% | 2.41% | 3.86% | 0.02% |
Rapid Micro Biosystems Net Income Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 |
Net Income | - | - | - | - | - | - | - | - | $-11.17M | $-13.39M | $-14.02M | $-13.89M | $-16.45M | $-16.34M | $-13.09M | $-14.93M | $-14.61M | $-24.99M | $-11.83M |
Avg Forecast | $-7.85M | $-8.29M | $-8.29M | $-9.60M | $-10.03M | $-10.56M | $-12.07M | $-12.65M | $-12.55M | $-13.38M | $-14.83M | $-15.92M | $-15.70M | $-26.76M | $-13.85M | $-14.03M | $-12.21M | $-16.90M | $-498.37M |
High Forecast | $-7.46M | $-7.88M | $-7.88M | $-9.12M | $-9.53M | $-10.50M | $-11.47M | $-12.02M | $-12.44M | $-12.71M | $-14.09M | $-15.13M | $-14.92M | $-21.41M | $-13.46M | $-11.22M | $-11.87M | $-16.42M | $-398.70M |
Low Forecast | $-8.24M | $-8.70M | $-8.70M | $-10.07M | $-10.53M | $-10.62M | $-12.67M | $-13.28M | $-12.66M | $-14.04M | $-15.57M | $-16.71M | $-16.48M | $-32.11M | $-14.24M | $-16.83M | $-12.56M | $-17.38M | $-598.05M |
Surprise % | - | - | - | - | - | - | - | - | 0.89% | 1.00% | 0.95% | 0.87% | 1.05% | 0.61% | 0.95% | 1.06% | 1.20% | 1.48% | 0.02% |
Rapid Micro Biosystems SG&A Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 |
SG&A | - | - | - | - | - | - | - | - | $8.70M | $9.70M | $9.93M | $9.93M | $11.26M | $11.12M | $9.89M | $9.55M | $9.12M | $8.37M | $6.75M |
Avg Forecast | $11.25M | $10.94M | $10.64M | $10.35M | $12.09M | $9.43M | $8.63M | $7.91M | $8.85M | $7.99M | $5.97M | $5.95M | $6.48M | $5.71M | $6.26M | $7.43M | $8.44M | $9.45M | $8.54M |
High Forecast | $11.68M | $11.36M | $11.05M | $10.75M | $12.55M | $9.47M | $8.96M | $8.22M | $8.97M | $8.29M | $6.20M | $6.18M | $6.72M | $5.93M | $6.40M | $7.59M | $8.63M | $9.66M | $8.72M |
Low Forecast | $10.82M | $10.53M | $10.24M | $9.96M | $11.63M | $9.38M | $8.30M | $7.61M | $8.73M | $7.68M | $5.74M | $5.72M | $6.23M | $5.49M | $6.12M | $7.27M | $8.26M | $9.24M | $8.35M |
Surprise % | - | - | - | - | - | - | - | - | 0.98% | 1.21% | 1.66% | 1.67% | 1.74% | 1.95% | 1.58% | 1.29% | 1.08% | 0.89% | 0.79% |
Rapid Micro Biosystems EPS Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 |
EPS | - | - | - | - | - | - | - | - | $-0.00 | $-0.31 | $-0.33 | $-0.32 | $-0.39 | $-0.38 | $-0.31 | $-0.35 | $-0.35 | $-0.71 | $-0.31 |
Avg Forecast | $-0.18 | $-0.19 | $-0.19 | $-0.22 | $-0.23 | $-0.24 | $-0.28 | $-0.29 | $-0.29 | $-0.31 | $-0.34 | $-0.36 | $-0.36 | $-0.37 | $-0.32 | $-0.34 | $-0.28 | $-0.39 | $-1.09 |
High Forecast | $-0.17 | $-0.18 | $-0.18 | $-0.21 | $-0.22 | $-0.24 | $-0.26 | $-0.28 | $-0.29 | $-0.29 | $-0.32 | $-0.35 | $-0.34 | $-0.35 | $-0.31 | $-0.33 | $-0.27 | $-0.38 | $-1.06 |
Low Forecast | $-0.19 | $-0.20 | $-0.20 | $-0.23 | $-0.24 | $-0.24 | $-0.29 | $-0.30 | $-0.29 | $-0.32 | $-0.36 | $-0.38 | $-0.38 | $-0.38 | $-0.33 | $-0.35 | $-0.29 | $-0.40 | $-1.12 |
Surprise % | - | - | - | - | - | - | - | - | 0.00% | 1.01% | 0.97% | 0.88% | 1.08% | 1.04% | 0.98% | 1.04% | 1.25% | 1.83% | 0.28% |
Rapid Micro Biosystems Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
BJDX | Bluejay Diagnostics | $0.15 | $10.00 | 6566.67% | Buy |
OWLT | Owlet | $4.03 | $196.00 | 4763.52% | Buy |
RPID | Rapid Micro Biosystems | $0.84 | $8.00 | 852.38% | Hold |
AZYO | Elutia | $1.49 | $10.25 | 587.92% | Buy |
OFIX | Orthofix Medical | $16.76 | $31.00 | 84.96% | - |
LUNG | Pulmonx | $8.31 | $12.25 | 47.41% | Buy |
LIVN | LivaNova | $48.53 | $71.25 | 46.82% | Buy |
KIDS | OrthoPediatrics | $32.28 | $40.80 | 26.39% | Buy |
RXST | RxSight | $54.96 | $68.60 | 24.82% | Buy |
SRDX | Surmodics | $39.36 | $39.50 | 0.36% | Buy |
BVS | Bioventus | $11.17 | $7.50 | -32.86% | Buy |
RPID Forecast FAQ
Is Rapid Micro Biosystems a good buy?
No, according to 1 Wall Street analysts, Rapid Micro Biosystems (RPID) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of RPID's total ratings.
What is RPID's price target?
Rapid Micro Biosystems (RPID) average price target is $8 with a range of $8 to $8, implying a 858.08% from its last price of $0.835. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Rapid Micro Biosystems stock go up soon?
According to Wall Street analysts' prediction for RPID stock, the company can go up by 858.08% (from the last price of $0.835 to the average price target of $8), up by 858.08% based on the highest stock price target, and up by 858.08% based on the lowest stock price target.
Can Rapid Micro Biosystems stock reach $1?
RPID's average twelve months analyst stock price target of $8 supports the claim that Rapid Micro Biosystems can reach $1 in the near future.
What are Rapid Micro Biosystems's analysts' financial forecasts?
Rapid Micro Biosystems's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $26.45M (high $27.24M, low $25.66M), average EBITDA is $-26.45M (high $-25.659M, low $-27.241M), average net income is $-45.311M (high $-43.525M, low $-47.097M), average SG&A $38.06M (high $39.2M, low $36.92M), and average EPS is $-1.039 (high $-0.998, low $-1.08). RPID's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $30.01M (high $31.16M, low $28.87M), average EBITDA is $-30.015M (high $-28.869M, low $-31.16M), average net income is $-34.021M (high $-32.332M, low $-35.709M), average SG&A $43.19M (high $44.84M, low $41.54M), and average EPS is $-0.78 (high $-0.741, low $-0.819).
Did the RPID's actual financial results beat the analysts' financial forecasts?
Based on Rapid Micro Biosystems's last annual report (Dec 2023), the company's revenue was $22.52M, beating the average analysts forecast of $19.98M by 12.69%. Apple's EBITDA was $-56.563M, beating the average prediction of $-19.983M by 183.05%. The company's net income was $-52.467M, missing the average estimation of $-56.675M by -7.42%. Apple's SG&A was $38.26M, beating the average forecast of $28.76M by 33.04%. Lastly, the company's EPS was $-0.0012, missing the average prediction of $-1.299 by -99.91%. In terms of the last quarterly report (Dec 2023), Rapid Micro Biosystems's revenue was $6.34M, beating the average analysts' forecast of $6.15M by 3.04%. The company's EBITDA was $-12.483M, beating the average prediction of $-6.15M by 102.98%. Rapid Micro Biosystems's net income was $-11.172M, missing the average estimation of $-12.549M by -10.97%. The company's SG&A was $8.7M, missing the average forecast of $8.85M by -1.72%. Lastly, the company's EPS was $-0.0003, missing the average prediction of $-0.288 by -99.90%